|1.||Moriyama, Noriyuki: 3 articles (05/2009 - 10/2004)|
|2.||Demirci, Ali: 2 articles (03/2010 - 10/2008)|
|3.||Inan, Nagihan: 2 articles (03/2010 - 10/2008)|
|4.||Akansel, Gur: 2 articles (03/2010 - 10/2008)|
|5.||Nasu, Katsuhiro: 2 articles (01/2007 - 10/2004)|
|6.||Nawano, Shigeru: 2 articles (01/2007 - 10/2004)|
|7.||Li, Xin-Feng: 1 article (05/2015)|
|8.||Hong, Ben-Zu: 1 article (05/2015)|
|9.||Lin, Jian-Qing: 1 article (05/2015)|
|10.||Wang, Lu: 1 article (02/2015)|
03/01/2012 - "The objective of this study is to estimate average annual health care expenditures for people with hemophilia covered by employer-sponsored insurance, stratified according to the influence of age, type of hemophilia [A (factor VIII deficiency) versus B (factor IX)], presence of neutralizing alloantibody inhibitors and exposure to blood-borne viral infections. "
03/01/1977 - "These studies indicate that, in addition to antecedent viral infections such as influenza B, factor(s) that are most likely extrinsic or environmental also play a role in the pathogenesis of Reye's syndrome."
|2.||Hemophilia A (Haemophilia)
11/01/2014 - "Consecutive, previously untreated patients with severe or moderate haemophilia A and B (factor VIII or IX activity <0.01 or 0.01-0.05 IU mL(-1) respectively) born between January 1st 2000 and January 1st 2010 were included. "
11/01/2009 - "Patients with severe hemophilia A or B (factor VIII/IX < 1%; the normal values were 50-200%) were examined. "
01/01/2000 - "One hundred and 16 patients contributed to an analysis of the impact of the consequences of severe haemophilia A or B (factor levels < 2%) on orthopaedic status, resources consumed in relation to this status and resultant cost, and quality of life as perceived by the patient, using the MOS 36-Item-Short-Form Health Survey (SF-36). "
01/01/1979 - "During the years 1975--77, 35 patients with haemophilia A or B (factor level of 1% or less) were instructed to administer concentrates of the deficient factor (mean dose 14 U/kg) i.v. in case of episodic, uncomplicated bleedings without prior consultation with a physician. "
01/01/1966 - "Method of detection of deficiencies of hemophilia A (8) and B factor (IX)."
|3.||Neoplasm Metastasis (Metastasis)
10/01/1990 - "Serosal invasion (S factor), direct hepatic invasion (H inf factor), lymph node metastasis (N factor), bile duct invasion (B factor), duodenal invasion (Du factor) and finally preoperative staging diagnosis were included in this study. "
07/01/2012 - "For all lesions, SPIO-T2*wI showed significantly higher confidence score in the diagnosis of hepatic metastases than pre-contrast or SPIO-DWI regardless of the size of b-factors (p<0.05) with only one exception; using b-factor=50 s/mm², the score of SPIO-T2*wI was still higher than SPIO-DWI but there was no statistical significance given by observer 1 (p=0.730). "
03/01/2010 - "With the b factor of 1000 sec/mm(2), both the signal intensity and lesion-to-liver signal intensity ratio of the metastases were significantly higher than those for haemangiomas (p<0.001). "
04/01/2009 - "We demonstrated the usefulness of diffusion-weighted imaging with a high b-factor to detect renal cancer presenting with peritoneal metastasis in a patient with ACDK."
09/01/2014 - "Forty-nine patients with infiltrating tumors (38 patients: low to high-grade gliomas) or vasogenic edema (11 patients: metastases, abscess, extra-axial lesions) were studied by multi-b factor diffusion-weighted imaging. "
|4.||Schizophrenia (Dementia Praecox)
|5.||Reye Syndrome (Reye's Syndrome)
|2.||Complement System Proteins (Complement)
|3.||Intergenic DNA (Junk DNA)
|4.||Gadolinium DTPA (Magnevist)
|6.||HLA-A Antigens (HLA-A)
|7.||Steroid 21-Hydroxylase (21 Hydroxylase)
|8.||Proteins (Proteins, Gene)
|9.||Protease Inhibitors (Protease Inhibitor)